Status:
COMPLETED
Predicting the Development of Myocardial Depression in Acute Neurological Patients
Lead Sponsor:
Ohio State University
Conditions:
Myocardial Depression
Takotsubo Syndrome
Eligibility:
FEMALE
50+ years
Brief Summary
The purpose of this study is to assess the levels of serum catecholamines associated with myocardial depression (MD) in patients with acute neurological injury.
Detailed Description
The purpose of this study is to investigate the level of plasma catecholamines, associated with myocardial depression (MD) as noted on Transthoracic ECHO (TTE) by evidence of wall motion abnormalities...
Eligibility Criteria
Inclusion
- female patients \>50 years admitted to the neuro ICU with diagnosis of either acute ischemic stroke or subarachnoid hemorrhage
- Only patients predicted to be on norepinephrine infusion for at least 48 hrs will be selected.
Exclusion
- patients with known history of heart failure will be excluded
- Patients with history of coronary artery disease, smoking, poorly controlled diabetes with HbA1c \>8 and uncontrolled hypertension will be excluded.
- Patients with poor ECHO windows will be excluded
Key Trial Info
Start Date :
December 3 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 14 2024
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT03801694
Start Date
December 3 2018
End Date
April 14 2024
Last Update
April 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio Sate University
Columbus, Ohio, United States, 43210